Close

Allogene Therapeutics (ALLO) shares plunge, company announces 22% workforce reduction Jan 5, 2024 09:16AM
Allogene Therapeutics Announces Participation in December Investor Conference Dec 1, 2023 08:30AM
Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences Apr 13, 2023 08:30AM
Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences Apr 13, 2023 08:30AM
Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences Nov 9, 2022 08:30AM


Nov 9, 2022 08:30AM Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences
Nov 12, 2021 08:30AM Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
Nov 12, 2021 08:30AM Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
May 20, 2021 08:30AM Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
May 20, 2021 08:30AM Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
Nov 12, 2020 08:30AM Allogene Therapeutics Announces November and December 2020 Virtual Investor Conference Participation
Nov 12, 2020 08:30AM Allogene Therapeutics Announces November and December 2020 Virtual Investor Conference Participation
Jun 3, 2020 08:30AM Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation
Jun 3, 2020 08:30AM Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation
May 31, 2020 05:46PM Allogene (ALLO) PT Raised to $53 at JMP Securities